Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study
- PMID: 22697195
- DOI: 10.4088/JCP.11m07099
Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study
Abstract
Objective: Although current attention-deficit/hyperactivity disorder (ADHD) diagnostic criteria do not include emotional symptoms, externalizing behavior problems, or aggression, the practicing clinician is often faced with the evaluation and management of these symptoms when assessing and treating patients with ADHD. While much research has focused on comorbid disorders in ADHD, less attention has been directed to comorbid symptoms that may or may not meet syndrome criteria but that influence ADHD treatment planning and outcome. The aim of this study is to describe emotional and behavioral symptoms in children and adolescents with ADHD and compare them with non-ADHD control groups.
Method: From 1995 to 2005, clinically referred children and adolescents with the combined subtype of ADHD (n = 175) or the inattentive subtype of ADHD (n = 70) as diagnosed by the primary physician (using DSM-IV criteria) were compared with a non-ADHD psychiatric control group (n = 65) and a non-ADHD community control group (n = 72) on measures that assessed emotional symptoms, externalizing behavior problems, and aggression; comparisons were controlled for age, sex, and family income.
Results: Both ADHD groups had depressive symptom severity equal to a non-ADHD psychiatric control group and greater than community control groups. Externalizing behavior problems and aggression were more severe in the ADHD combined subtype group compared with other groups. As ADHD symptom severity increased, externalizing behavior problems and aggression, but not internalizing symptoms, also increased in severity. Family income had an independent relationship with externalizing disorders.
Conclusions: High rates of internalizing emotional symptoms, externalizing problem behaviors, and aggression were found in a clinical ADHD sample. Externalizing behavior problems and aggression appeared to be related to the hyperactive-impulsive ADHD symptom domain and to overall ADHD symptom severity. It remains an empirical question as to whether effective treatment of the core symptoms of ADHD will also reduce the presence of associated emotional and behavioral symptoms and improve daily functioning in children and adolescents with ADHD.
© Copyright 2012 Physicians Postgraduate Press, Inc.
Similar articles
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children.J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):503-14. doi: 10.1097/00004583-199704000-00013. J Am Acad Child Adolesc Psychiatry. 1997. PMID: 9100425
-
Correlates of comorbid psychopathology in children with ADHD.J Am Acad Child Adolesc Psychiatry. 2003 Feb;42(2):193-200. doi: 10.1097/00004583-200302000-00013. J Am Acad Child Adolesc Psychiatry. 2003. PMID: 12544179
-
Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.J Clin Psychiatry. 1998;59 Suppl 7:50-8. J Clin Psychiatry. 1998. PMID: 9680053 Review.
-
[The course of attention deficit hyperactivity disorder (ADHD) over the life span].Psychiatriki. 2012 Jun;23 Suppl 1:49-59. Psychiatriki. 2012. PMID: 22796973 Review. Greek, Modern.
Cited by
-
Effect of methylphenidate and folic Acid on ADHD symptoms and quality of life and aggression: a randomized double blind placebo controlled clinical trial.Iran J Psychiatry. 2013 Aug;8(3):108-12. Iran J Psychiatry. 2013. PMID: 24454418 Free PMC article.
-
Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.Psychopharmacology (Berl). 2014 Sep;231(17):3635-45. doi: 10.1007/s00213-014-3514-5. Epub 2014 Mar 6. Psychopharmacology (Berl). 2014. PMID: 24599397
-
The role of sleep problems and circadian clock genes in attention-deficit hyperactivity disorder and mood disorders during childhood and adolescence: an update.J Neural Transm (Vienna). 2017 Feb;124(Suppl 1):127-138. doi: 10.1007/s00702-015-1455-8. Epub 2015 Oct 15. J Neural Transm (Vienna). 2017. PMID: 26471800 Review.
-
Adult ADHD and emerging models of maladaptive personality: a meta-analytic review.BMC Psychiatry. 2021 Jun 1;21(1):282. doi: 10.1186/s12888-021-03284-1. BMC Psychiatry. 2021. PMID: 34074265 Free PMC article.
-
Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes.Int J Mol Sci. 2014 Sep 25;15(9):17115-29. doi: 10.3390/ijms150917115. Int J Mol Sci. 2014. PMID: 25257531 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials